AILERON THERAPEUTICS
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.
AILERON THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aileronrx.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 995 0900
Email Addresses:
[email protected]
Total Funding:
218.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
![]()
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
![]()
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
![]()
![]()
![]()
Current Employees Featured

![]()

Founder
![]()
Stock Details
Investors List
![]()
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Secondary - Aileron Therapeutics
Acorn Bioventures
Acorn Bioventures investment in Post-IPO Secondary - Aileron Therapeutics

Grand Oaks Capital
Grand Oaks Capital investment in Post-IPO Secondary - Aileron Therapeutics
![]()
Satter Investment Management
Satter Investment Management investment in Post-IPO Secondary - Aileron Therapeutics

Maven Investment Partners US
Maven Investment Partners US investment in Post-IPO Secondary - Aileron Therapeutics
BVF Partners
BVF Partners investment in Post-IPO Secondary - Aileron Therapeutics
![]()
Novartis Venture Fund
Novartis Venture Fund investment in Series E - Aileron Therapeutics
![]()
Excel Venture Management
Excel Venture Management investment in Series E - Aileron Therapeutics
![]()
Roche Venture Fund
Roche Venture Fund investment in Series E - Aileron Therapeutics
Lilly Ventures
Lilly Ventures investment in Series E - Aileron Therapeutics
Key Employee Changes
Official Site Inspections
http://www.aileronrx.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
